US equities |
MU $913.13 ▲+4.06% TSLA $395.35 ▲+6.21% NVDA $216.21 ▲+2.49% SPCX $148.52 ▲+0.70% META $636.09 ▼-1.02% AAPL $343.57 ▼-1.19% SNDK $1,275.02 ▲+2.99% INTC $91.81 ▲+5.58%
FinancialContent

Zivo Bioscience, Inc. - Common Stock (NQ:ZIVO)

N/A UNCHANGED
Last Price Updated: 1:00 PM EST, Nov 24, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Zivo Bioscience, Inc. - Common Stock

News headline image
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Announces Uplisting to OTCQB Market
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Announces Reverse Stock Split
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
From Zivo Bioscience, Inc.
Via GlobeNewswire
News headline image
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Receives $1 Million Bridge Financing
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience CEO Issues Letter to Shareholders
From Zivo Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
Zivo Bioscience Joins Russell Microcap® Index
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
From ZIVO Bioscience, Inc.
Via Business Wire
News headline image
Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
From Stock News Now
Via AccessWire
Topics Cannabis